Skip to content

Association Between Pococyturia and Pre-eclampsia Severity

Prospective Study : Association Between Pococyturia and Pre-eclampsia Severity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03316391
Acronym
PEPOD2
Enrollment
14
Registered
2017-10-20
Start date
2019-05-22
Completion date
2021-03-02
Last updated
2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-Eclampsia

Brief summary

Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious maternal, fetal and neonatal mortality and morbidity. Twenty four hours proteinuria is a key element to define pre-eclampsia severity but is delaying the result by 24 hours and constraining for the patient. A simple and rapid indicator for severe preeclampsia would help clinicians to make appropriate decision in patient management. We hypothesized that urinary podocyturia is correlated to preeclampsia severity. This is a prospective, non-interventional, monocentric study.

Interventions

OTHERDosage of urinary podocyturia

Dosage of urinary podocyturia at admission, delivery and post-partum visit

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women aged 18 years or more * single pregnancy * admission for pre-eclampsia * patient receiving information and non-opposition to participate

Exclusion criteria

* multiple pregnancy * in utero fetal demise excepted if associated with pre-eclampsia * antecedent of nephropathy * fetal malformation, chromosomal anomalies * inability to understand information provided * prisoner or under administrative supervision

Design outcomes

Primary

MeasureTime frameDescription
Severity of pre-eclampsiaat childbirth (maximum 10 months)Severe preeclampsia is defined by preeclampsia with at least one of the following criteria : * severe hypertension (PAS ≥ 160 mmHg et/ou PAD ≥ 110 mmHg) * Renal impairment with: oliguria \<500 ml / 24h or creatinine\> 135 μmol / L or proteinuria\> 5 g/d * acute lung edema or persistent epigastric bar or HELLP syndrome * eclampsia or rebellious neurological disorders (visual disturbances, polykinetic ROT, headache), * thrombocytopenia \<100 G / L * Retro Placental Hematoma (HRP) or fetal repercussion.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026